Home
Cardiac Support
Company
News
Contact

News

CardiacBooster Secures €9.3 Million DTIF Funding to Revolutionize Treatment of Cardiogenic Shock

CardiacBooster Secures €9.3 Million DTIF Funding to Revolutionize Treatment of Cardiogenic Shock

Developing the next generation of percutaneous left ventricular assist devices.

Home
Cardiac Support
Company
News
Contact

© All Rights Reserved